1 |
Hambach L, Goulmy E: Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Imunol 17;202-210, 2005
DOI
ScienceOn
|
2 |
Blair AN, Goulden J, Libri NA, Oakhill A, Pamphilon DH: Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation. Blood 19;289-300, 2005
DOI
ScienceOn
|
3 |
Antoniou A, McCormick D, Scott D, Yeoman H, Chandler P, Mellor A, Dyson J: T cell tolerance and activation to a transgene-encoded tumor antigen. Eur J Immunol 26;1094-1102, 1996
DOI
ScienceOn
|
4 |
van Essen D, Kikutani H, Gray D: CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature 378;620-623, 1995
DOI
ScienceOn
|
5 |
Lefrancois L, Altman JD, Williams K, Olson S: Soluble antigen and CD40 triggering are sufficient to induce primary and memory cytotoxic T cells. J Immunol 164;725-732, 2000
DOI
PUBMED
|
6 |
Lee BO, Hartson L, Randall TD: CD40-deficient, influenzaspecific CD8 memory T cells develop and function normally in a CD40-sufficient environment. J Exp Med 198;1759-1764, 2003
DOI
ScienceOn
|
7 |
Ozaki ME, Coren BA, Huynh TN, Redondo DJ, Kikutani H, Webb SR: CD4+ T cell responses to CD40-deficient APCs: defects in proliferation and negative selection apply only with B cells as APCs. J Immunol 163;5250-5256, 1999
PUBMED
|
8 |
Matloubian M, Concepcion RJ, Ahmed R: CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68;8056-8063, 1994
PUBMED
|
9 |
Wallny HJ, Rammensee HG: Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature 343;275-278, 1990
DOI
ScienceOn
|
10 |
Lanzavecchia A: Immunology. Licence to kill. Nature 393;413-414, 1998
DOI
ScienceOn
|
11 |
Bourgeois C, Rocha B, Tanchot C: A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297;2060-2063, 2002
DOI
ScienceOn
|
12 |
Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421;852-856, 2003
DOI
ScienceOn
|
13 |
Noelle RJ: CD40 and its ligand in host defense. Immunity 4;415-419, 1996
DOI
ScienceOn
|
14 |
Grewal IS, Flavell RA: CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol 16;111-135, 1998
DOI
ScienceOn
|
15 |
Scott D, Addey C, Ellis P, James E, Mitchell MJ, Saut N, Jurcevi S, Simpson E: Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity 12;711-720, 2000
DOI
ScienceOn
|
16 |
Sun JC, Bevan MJ: Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300;339-342, 2003
DOI
ScienceOn
|
17 |
Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G: High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 184;741-746, 1996
DOI
|
18 |
Whitmire JK, Flavell RA, Grewal IS, Larsen CP, Pearson TC, Ahmed R: CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol 163;3194-3201, 1999
PUBMED
|
19 |
Belz GT, Wodarz D, Diaz G, Nowak MA, Doherty PC: Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76;12388-12393, 2002
DOI
|
20 |
Hermann P, Van-Kooten C, Gaillard C, Banchereau J, Blanchard D: CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur J Immunol 25;2972-2977, 1995
DOI
ScienceOn
|
21 |
VanderVegt FP, Johnson LL: Induction of long-term H-Y-specific tolerance in female mice given male lymphoid cells while transiently depleted of CD4+ or CD8+ T cells. J Exp Med 177;1587-1592, 1993
DOI
|
22 |
Stout RD, Suttles J, Xu J, Grewal IS, Flavell RA: Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol 156;8-11, 1996
PUBMED
|